Discover 1,955 paid clinical trials in Plano, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,955
A Study of Venoarterial ECMO vs Off-Pump Bilateral Orthotopic Lung Transplantation
Location: Dallas TX, Houston TX, Kansas City MO, Birmingham AL,
Sponsor: NICHD Neonatal Research Network
Sex: All
Age: 1 - 2
Code: NCT00009633
Recruiting
ARTIDIS Nanomechanical Generated Measurements for Early Breast Lesions
for
Breast Cancer
Location: Dallas TX, Houston TX, Seattle WA
Sponsor: ARTIDIS AG
Sex: All
Age: 18+
Code: NCT06085833
Recruiting
Abatacept in Immune Checkpoint Inhibitor Myocarditis
for
Myocarditis Acute, Cancer
Location: Dallas TX, Kansas City KS, Indianapolis IN,
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT05335928
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
IDH Targeted/Non- Targeted vs Non-targeted/IDH-targeted Approaches in the Treatment of Newly Diagnosed IDH Mutated AML Patients Not Candidates for Intensive Induction Therapy (I- DATA Study)
for
Acute Myeloid Leukemia
Location: Dallas TX, Aurora CO, Columbus OH, Chapel Hill NC
Sponsor: Alice Mims
Sex: All
Age: 18+
Code: NCT05401097
Phase 2, Recruiting
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
for
Rheumatic Joint Disease
Location: Dallas TX, Houston TX, Jackson MS, Kansas City MO,
Sponsor: Duke University
Sex: All
Age: 0 - 21
Code: NCT02418442
Recruiting
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
for
Liver Diseases, Alcoholic
Location: Dallas TX, Arlington TX, Fort Worth TX, Georgetown TX,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18 - 70
Code: NCT06613698
Phase 2, Recruiting
Study of Biomarker-Based Treatment of Acute Myeloid Leukemia
Location: Dallas TX, Fairway KS, Atlanta GA, Chicago IL,
Sponsor: Beat AML, LLC
Sex: All
Age: 18+
Code: NCT03013998
Phase 2, Phase 3, Recruiting
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
for
Sarcoma
Location: Dallas TX, Fort Worth TX, Oklahoma City OK,
Sponsor: University of Leicester
Sex: All
Age: 0 - 49
Code: NCT00020566
Phase 3, Recruiting
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
for
Non-muscle-invasive Bladder Cancer
Location: Dallas TX, Fort Worth TX, Houston TX, San Antonio TX,
Sponsor: SURGE Therapeutics
Sex: All
Age: 18+
Code: NCT05710848
Phase 1, Phase 2, Recruiting
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
Location: Plano TX, Dallas TX, Fort Worth TX, Tyler TX,
Sponsor: Medtronic
Sex: All
Age: 0+
Code: NCT00271180
Recruiting
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
for
Mesothelioma, Non Small Cell Lung Cancer,
Location: Dallas TX, Fort Worth TX, Tyler TX, Houston TX,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT05245500
Phase 1, Recruiting
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Location: Dallas TX, Shreveport LA, Oklahoma City OK, Austin TX,
Sponsor: Sameek Roychowdhury
Sex: All
Age: 18+
Code: NCT06906562
Phase 2, Recruiting
Diagnosing Epilepsy To EffeCT Change
for
Epilepsy, Epilepsy (Treatment Refractory)
Location: Dallas TX, Houston TX, St Louis MO, Birmingham AL,
Sponsor: Epiminder America, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07110337
Recruiting
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
for
Multiple Myeloma
Location: Dallas TX, Denver CO, Atlanta GA, Cincinnati OH,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06892522
Phase 1, Phase 2, Recruiting
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)